Log in

Relevant bibliographies by topics / Pharmaceutical policy / Dissertations / Theses

To see the other types of publications on this topic, follow the link: Pharmaceutical policy.

Dissertations / Theses on the topic 'Pharmaceutical policy'

Author: Grafiati

Published: 4 June 2021

Last updated: 25 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 dissertations / theses for your research on the topic 'Pharmaceutical policy.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.

1

Lee, Iynhyang. "Evaluating pharmaceutical policy in South Korea." Thesis, University of York, 2010. http://etheses.whiterose.ac.uk/14150/.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Kiatying-Angsulee, Niyada. "Pharmaceutical registration policy in Thailand : development and implementation." Thesis, London School of Hygiene and Tropical Medicine (University of London), 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.392683.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Permanand, Govin. "Regulating under constraint : the case of EU pharmaceutical policy." Thesis, London School of Economics and Political Science (University of London), 2003. http://etheses.lse.ac.uk/1940/.

Full text

Abstract:

This study is concerned with the making of regulatory policy for pharmaceuticals in the European Union. It proposes that an ad hoc development of Community competencies which does not amount to coherent strategy, far less a single medicines market, has resulted in a regulatory framework which favours the interests of industry. This is important on two fronts. First, it appears to run counter to contemporary research into EU regulation, which finds that consumer interests prevail over those of producers generally. Second, this pro-industry leaning seems not to be in keeping with member states'

APA, Harvard, Vancouver, ISO, and other styles

4

Ozierański, Piotr. "Who rules postcommunism? : the case of drug reimbursement policy in Poland." Thesis, University of Cambridge, 2012. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.610488.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Granlund, David. "Economic policy in health care : Sickness absence and pharmaceutical costs." Doctoral thesis, Umeå : Department of Economics, Umeå University, 2007. http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1137.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Hayashi, Yuko. "Japanese government policy to innovative R&D in pharmaceutical industry." Thesis, Massachusetts Institute of Technology, 1994. http://hdl.handle.net/1721.1/35990.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Sales, Raquel da Silva. "National Drug Policy, Decentralization, Pharmaceutical Assistance, Essential Medicines, Access to medicines." Universidade Federal do CearÃ, 2008. http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=2937.

Full text

Abstract:

nÃo hÃ<br>This dissertation aims to investigate the influence of drugs decentralization policy on the free access to medicine in the Northeast region, which started after the publication of the National Drug Policy (NDP). As a result, using the microdata special supplement of Health from PNAD 1998 (year before the issue of the NDP) and 2003 (five years after the NDP), it was estimated nine functional forms of logit model with fixed effect for the nine states of Northeast Brazil. The results implies that, after the policy, the probability to free medicines access was improved for almost all sta

APA, Harvard, Vancouver, ISO, and other styles

8

Corvari, Ronald J. (Ronald Joseph) Carleton University Dissertation Economics. "Strategic advertising behaviour and public policy in the Canadian pharmaceutical industry." Ottawa, 1991.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Kundu, Jayeeta. "Cross-country study on the promotion of new pharmaceutical products." Thesis, Massachusetts Institute of Technology, 2006. http://hdl.handle.net/1721.1/34524.

Full text

Abstract:

Thesis (S.M.)--Massachusetts Institute of Technology, Engineering Systems Division, Technology and Policy Program, 2006.<br>Includes bibliographical references (p. 170-176).<br>Detailers are one of the most powerful components of pharmaceutical marketing. Drug manufactures spend a lion's share of their marketing budgets on their detailers, and with direct-to-consumer (DTC) marketing coming under closer scrutiny, it is likely that detailing will receive even more funding in the coming years. This thesis analyzes how differences in detailing regulations in the United States, United Kingdom, Swed

APA, Harvard, Vancouver, ISO, and other styles

10

Boothe, Katherine. "Pharmaceutical programs and social policy development: comparing Canada, Australia and the UK." Thesis, University of British Columbia, 2010. http://hdl.handle.net/2429/26266.

Full text

Abstract:

Canada is the only OECD country that provides broad public health benefits but lacks a universal, nation-wide system for funding prescription drugs. This puzzle cannot be explained by the literature on national health insurance, which suggests that the tendency to consider all health services as a single policy has missed an important source of cross-national variation. How can we explain the lack of a major pharmaceutical program in Canada, in light of the country’s own extensive health system and the experience of almost all other welfare states? More generally, why do some countries adopt u

APA, Harvard, Vancouver, ISO, and other styles

11

Lagarde, Loïc (Loïc Jean Georges). "Exploring the future of the U.S. pharmaceutical industry : a supply chain perspective." Thesis, Massachusetts Institute of Technology, 2007. http://hdl.handle.net/1721.1/40294.

Full text

Abstract:

Thesis (S.M.)--Massachusetts Institute of Technology, Engineering Systems Division, Technology and Policy Program, 2007.<br>This electronic version was submitted by the student author. The certified thesis is available in the Institute Archives and Special Collections.<br>Includes bibliographical references (p. 76-80).<br>This thesis uses an innovative approach to explore the much-analyzed U.S. Healthcare system. To be sure, we are fully aware of the challenges involved in making robust system level policy recommendations and how local inefficiencies and hidden uncertainties undermine attempt

APA, Harvard, Vancouver, ISO, and other styles

12

Lim, Sang Hun. "Regulation of the pharmaceutical market in the South Korean National Health Insurance." Thesis, University of Oxford, 2011. http://ora.ox.ac.uk/objects/uuid:0866cb3c-9939-4ccf-9d1f-d16c7f689f41.

Full text

Abstract:

This thesis explores the implications of democratisation on the regulation of health care providers. It examines the reforms in relation to two regulatory policies in the pharmaceutical market of the National Health Insurance (NHI) in South Korea – the separation of prescribing and dispensing (SPD) and the pharmaceutical pricing policy – conducted in two periods – the 1980s under the authoritarian regime and the 1990s under the democratised regime. The misuse and overuse of drugs had long been recognised as a problem for the NHI, and the tight regulation of the SPD and pharmaceutical pricing a

APA, Harvard, Vancouver, ISO, and other styles

13

Lofgren, Hans. "Globalisation of the pharmaceutical industry and the Australian state : the transformation of a policy network /." Connect to thesis, 1997. http://eprints.unimelb.edu.au/archive/00000300.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Wickham, Cheryl E. "Government pharmaceutical subsidy policy and the demand for health care in Russia : evidence from the Russia longitudinal monitoring survey /." Thesis, Connect to this title online; UW restricted, 2000. http://hdl.handle.net/1773/7513.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Vernon, John A. "The economics of pharmaceutical research development : investment models, capital market imperfections and policy considerations." Thesis, City University London, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.367264.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Wei, Wei. "The value of pharmaceutical R&D projects under uncertainty and drug approval policy." Thesis, University of York, 2016. http://etheses.whiterose.ac.uk/17815/.

Full text

Abstract:

Pharmaceutical R&D projects often have the characteristics of irreversibility on investment, flexibility of investment timing, and uncertainty in cash flows. In this thesis, the real options approach is used as the evaluation tool for these projects and three continuous-time investment models are developed. In chapter 4, we discuss the effects of the investment lag and commercialization flexibility on the investment decisions under uncertainty. Chapter 5 examines which organizational structures, the decentralized or centralized pharmaceutical R&D project, are more socially desirable in terms o

APA, Harvard, Vancouver, ISO, and other styles

17

Arana, Kevin, Katherinee Flores, Edgar Ramos, Timothy Pettit, and Monica Flanigan. "Service level of pharmaceutical supply chain applying optimal policy: Case study in Lima, Peru." ExcelingTech, 2020. http://hdl.handle.net/10757/653831.

Full text

Abstract:

El texto completo de este trabajo no está disponible en el Repositorio Académico UPC por restricciones de la casa editorial donde ha sido publicado.<br>The present research seeks to show the importance of applying process management techniques and food safety norms in the operational processes of the supply chain to know the meaning and the need for an integrated hybrid model. The article reviews the sugarcane distillery sector of Peru and its main operational problems. Based on the literature reviewed and discussed with academics who have knowledge of the food supply chain, an integrated hybr

APA, Harvard, Vancouver, ISO, and other styles

18

Pokorny, Adrian. "Australian cancer physicians and the pharmaceutical industry: understanding current interactions to guide future policy." Thesis, The University of Sydney, 2022. https://hdl.handle.net/2123/29531.

Full text

Abstract:

Medical oncologists and clinical haematologists, defined together as cancer physicians, prescribe medications that treat cancer. Cancer physicians are a source of focus for influence by the pharmaceutical industry, and may accordingly be at risk of bias to the detriment of cancer patients. The aim of this thesis was to understand the nature and extent of interactions between Australian cancer physicians and industry, to better inform policy discussions in this area. A mixed-methods approach was used, consisting of four studies. A systematic review of the literature assessed relationships betw

APA, Harvard, Vancouver, ISO, and other styles

19

Usar, Joseph Iornumbe. "An economic analysis of retail pharmaceutical market in Nigeria : towards access expansion and policy." Thesis, Queen Margaret University, 2014. https://eresearch.qmu.ac.uk/handle/20.500.12289/7466.

Full text

Abstract:

Rural areas in much of sub-Saharan Africa access needed health care from untrained and often poorly regulated drug vendor shops with concerns over the quality of products and services provided and their public health implications. The thesis undertook to understand market relationships in a rural retail drug market in the light of the structure-conduct-performance paradigm and isolate opportunities for potential policy interventions for improved access to quality and safer medicines. Data was collected from a sample of patent medicine vendors and drug purchasers in Katsina-Ala Local Government

APA, Harvard, Vancouver, ISO, and other styles

20

Randall, Tina S. (Tina Sofia) 1972. "Analysis of the introduction of new technologies to evaluate the performance of pharmaceutical unit operations." Thesis, Massachusetts Institute of Technology, 1998. http://hdl.handle.net/1721.1/9930.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Pustejovsky, James. "Parallel Importation of Pharmaceuticals: When is international exhaustion an effective policy choice?" Thesis, Boston College, 2003. http://hdl.handle.net/2345/431.

Full text

Abstract:

Thesis advisor: James Anderson<br>National policy regarding parallel importation determines whether prices for a good protected by intellectual property rights are set in a segmented national market or in a larger international market. The innovative pharmaceutical industry has a cost structure which depends on patents and other intellectual property rights in order to recover the large sunk costs of research and development; parallel imports affect the ability of pharmaceutical firms to recover those costs. After discussing the international political context of parallel importation policy, i

APA, Harvard, Vancouver, ISO, and other styles

22

Rodrigues, Camila Lins 1982. "Políticas de saúde, desenvolvimento tecnológico e medicamentos = lições do caso brasileiro." [s.n.], 2012. http://repositorio.unicamp.br/jspui/handle/REPOSIP/285920.

Full text

Abstract:

Orientador: Pedro Luiz Barros Silva<br>Dissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Economia<br>Made available in DSpace on 2018-08-20T09:06:11Z (GMT). No. of bitstreams: 1 Rodrigues_CamilaLins_M.pdf: 2244031 bytes, checksum: 943fc02d25c2a13cb8bbb7920d5e79a0 (MD5) Previous issue date: 2012<br>Resumo: As nações desenvolvidas conseguiram consolidar tanto a construção de Sistemas de Proteção Social, quanto a construção de Sistemas de Inovação. Por um lado, políticas sociais em áreas fundamentais e estratégicas como saúde, educação e previdência ganharam espaço privil

APA, Harvard, Vancouver, ISO, and other styles

23

Sweeny, Kim. "Accounting for growth in the Pharmaceutical Benefits Scheme." full-text, 2008. http://eprints.vu.edu.au/1960/1/sweeny.pdf.

Full text

Abstract:

This thesis investigates the contribution to the growth in expenditure on medicines listed on the Pharmaceutical Benefits Scheme (PBS) from three inter-related sources: (i) the addition of new medicines offering an expanding range of treatments for disease, (ii) PBS processes for determining the prices of medicines and their conditions of listing and (iii) the demand by patients for PBS medicines. In doing so it uses trend analysis presented in both tabular and graphic form, expenditure decomposition techniques based on index and indicator numbers, and econometric analysis. Using novel techniq

APA, Harvard, Vancouver, ISO, and other styles

24

Rees, Michael Douglass 1975. "Human capital movement : effects on research productivity in the pharmaceutical industry." Thesis, Massachusetts Institute of Technology, 1999. http://hdl.handle.net/1721.1/84206.

Full text

Abstract:

Thesis (S.M.)--Massachusetts Institute of Technology, Dept. of Mechanical Engineering; and, (S.M.)--Massachusetts Institute of Technology, Sloan School of Management, Technology and Policy Program, 1999.<br>Includes bibliographical references (leaves 60-63).<br>by Michael Douglass Rees.<br>S.M.

APA, Harvard, Vancouver, ISO, and other styles

25

McHugh, Patrick. "The Political Economy of Pharmaceutical Intellectual Property Rights: Balancing Innovation and Access." Master's thesis, Vysoká škola ekonomická v Praze, 2012. http://www.nusl.cz/ntk/nusl-125188.

Full text

Abstract:

The trade-off between innovation and access is a critical problem in pharmaceutical innovation policy. Without adequate intellectual property protection, knowledge is insufficiently appropriable and the output of innovation is sub-optimal. Patents and sui generis forms of intellectual property are policies utilized by the state to foster innovation, creating temporary monopolies for firms to reward their investments in research and development. This paper explores the topic of pharmaceutical innovation policy by discovering the key legal developments that influence the creation of internationa

APA, Harvard, Vancouver, ISO, and other styles

26

Ebohon, S. I. "Nigerian policy towards foreign companies : Case study of the multinational pharmaceutical formulation plants, 1972-1983." Thesis, University of Manchester, 1985. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.374791.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Ebenezer, C. J. "Pharmaceutical quality and policy in Nigeria : stakeholder perspectives and validation of the Mobile Authentication Service." Thesis, University College London (University of London), 2015. http://discovery.ucl.ac.uk/1461259/.

Full text

Abstract:

Background: Medicines that are of poor quality present a challenge to many countries especially the developing countries. Many interventions against medicines counterfeiting are often not evaluated and qualitative fieldwork to find how stakeholders perceive the problem of poor quality medicines is currently lacking. Aims: 1) To conduct a systematic review of the literature; 2) To validate the Mobile Authentication Service (MAS); 3) To explore stakeholder experiences and perceptions of the current situation of medicines counterfeiting and quality of medicines distributed in Nigeria. Methods: 1)

APA, Harvard, Vancouver, ISO, and other styles

28

Maahs, Michael Keith. "Medical Academia Conflict of Interest Policy and Potential Impact on Research Funding." ScholarWorks, 2015. http://scholarworks.waldenu.edu/dissertations/1317.

Full text

Abstract:

Medical Academia Conflict of Interest Policy and Potential Impact on Research Funding by Michael K. Maahs MPA, Troy University, 1993 BA, Ripon College, 1990 Dissertation Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Public Policy and Administration Walden University July 2015 The partnership between medical academia and the pharmaceutical industry has been scrutinized for issues associated with research bias. As a result of this scrutiny, the Institute of Medicine (IOM) issued policy recommendations in 2009 directing academia to adopt comprehensive

APA, Harvard, Vancouver, ISO, and other styles

29

Pleil, Andreas M. "Content analysis of selected pharmaceutical monographs in commercial drug compendia : an international comparison /." The Ohio State University, 1986. http://rave.ohiolink.edu/etdc/view?acc_num=osu1487267546981741.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Nazareno, Regina Céli Scorpione. "Decentralisation of pharmaceutical assistance in Brazil : impacts on access to medicines." Thesis, Brunel University, 2013. http://bura.brunel.ac.uk/handle/2438/8999.

Full text

Abstract:

This thesis explores how decentralisation of basic pharmaceutical assistance was introduced in Brazil. Decentralisation aimed to improve access to basic medicines. Nevertheless, the inconsistency in the availability of medicines in the Brazilian public health system (SUS - Unified Health System) justified the development of two seemingly contradictory, yet co-existing, approaches: decentralisation and recentralisation. The central question of my thesis was how the simultaneous processes of decentralisation and recentralisation, which took place between 1998 and 2011, have affected access to me

APA, Harvard, Vancouver, ISO, and other styles

31

Sweeny, Kim. "Accounting for growth in the Pharmaceutical Benefits Scheme." Thesis, full-text, 2008. https://vuir.vu.edu.au/1960/.

Full text

Abstract:

This thesis investigates the contribution to the growth in expenditure on medicines listed on the Pharmaceutical Benefits Scheme (PBS) from three inter-related sources: (i) the addition of new medicines offering an expanding range of treatments for disease, (ii) PBS processes for determining the prices of medicines and their conditions of listing and (iii) the demand by patients for PBS medicines. In doing so it uses trend analysis presented in both tabular and graphic form, expenditure decomposition techniques based on index and indicator numbers, and econometric analysis. Using novel techniq

APA, Harvard, Vancouver, ISO, and other styles

32

Chan, Leong. "Developing a Strategic Policy Choice Framework for Technological Innovation: Case of Chinese Pharmaceuticals." PDXScholar, 2013. https://pdxscholar.library.pdx.edu/open_access_etds/1041.

Full text

Abstract:

With the growing trend of globalization and rapid development of high technologies, emerging economies face more challenges in technology development because they are chasing a fast-moving frontier. They need to identify global technology trends and adapt to local needs and capabilities. Strategies for technology development differ among countries at different developmental stages. In this research, a technology policy choice framework is developed to link prospective high-tech areas, technology development strategies, and various innovative resources. The research approach is to develop a hie

APA, Harvard, Vancouver, ISO, and other styles

33

Tordoff, June Margaret, and n/a. "Evaluating the impact of a national hospital pharmaceutical strategy in New Zealand." University of Otago. School of Pharmacy, 2007. http://adt.otago.ac.nz./public/adt-NZDU20070712.151527.

Full text

Abstract:

Background: In September 2001, in addition to their existing management of primary care pharmaceutical expenditure, PHARMAC, the New Zealand government�s Pharmaceutical Management Agency, was authorized to manage pharmaceutical expenditure in public hospitals.[1] In February 2002 PHARMAC launched a three-part Strategy, the National Hospital Pharmaceutical Strategy (NHPS), for this purpose.[2] The Strategy focused on Price Management (PM), the Assessment of New Medicines (ANM), and promoting Quality in the Use of Medicines (QUM). Major initiatives planned were: for PM, to negotiate new, nationa

APA, Harvard, Vancouver, ISO, and other styles

34

Vogler, Sabine, August Österle, and Susanne Mayer. "Socioeconomic determinants of medicines use in Central Eastern Europe: the role of pharmaceutical policy in reducing inequalities." BioMed Central, 2015. http://epub.wu.ac.at/5145/1/Vogler_etal_2015_JPPP_Socioeconomic%2Ddeterminants.pdf.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Larsen, David Mark. "The discursive function and the embedding of capitalism : British state policy on the pharmaceuticals and biotechnology sector." Thesis, University of Cambridge, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.608970.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Gilligan, Adrienne M. "Health Shocks in Patients with Cancer: A Longitudinal Analysis of Financial and Retirement Trends Using the Health and Retirement Study." Diss., The University of Arizona, 2013. http://hdl.handle.net/10150/293483.

Full text

Abstract:

Objectives: Evaluate the association of cancer on net worth, consumer debt, mortgage debt, home equity and changes in retirement trends. Methods: Data from the Health and Retirement Study from 1998-2010 was used. Persons had to have a diagnosis of cancer. The index date was the corresponding HRS wave of the year of the first diagnosis of cancer. The pre-index date was 2 years and a 2-year and 4-year post index was observed. Primary outcomes of interest were zero/negative net worth and net worth. Multiple logistic regression was used to test for the association between demographic, economi

APA, Harvard, Vancouver, ISO, and other styles

37

Noh, In Joon. "Essays on Drivers of Quality and Compliance Performance in the Pharmaceutical Industry: Policy, Manufacturing Strategy, and Organizational Learning Perspectives." The Ohio State University, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=osu1595014194719331.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Knoesen, Brent Claud. "Influence of pharmaceutical advertising on consumers: an exploratory descriptive study." Thesis, Nelson Mandela Metropolitan University, 2007. http://hdl.handle.net/10948/658.

Full text

Abstract:

Pharmaceutical advertising involves the advertising of medicines, medical devices, and healthcare services. A review of available international literature indicates the belief that pharmaceutical advertisements negatively affect healthcare decisions made by consumers. Very little research has been conducted to determine how consumers in South Africa (SA) are affected by pharmaceutical advertisements. This study aimed to determine how consumers in the Nelson Mandela Metropole (NMM) perceive pharmaceutical advertisements. More specific objectives included the investigation of legislation in SA e

APA, Harvard, Vancouver, ISO, and other styles

39

Tran, Ngoc Nha Tinh. "EU Competition Law under Ordoliberalism - A case study of Excessive Pricing in Pharmaceutical Sector." Thesis, Malmö universitet, Fakulteten för kultur och samhälle (KS), 2020. http://urn.kb.se/resolve?urn=urn:nbn:se:mau:diva-23820.

Full text

Abstract:

The purpose of this study is to conceptualize the ideational influence of Ordoliberalism on EU Competition Law while addressing a problematic social issue that has been witnessing a surge in the number of cases, which is excessive price abuse under Article 102(a) of the Treaty on the Functioning of the European Union (TFEU) within the spectrum of pharmaceutical sector. By utilizing Nedergaard (2020)’s analytic framework for Ordoliberalism’s operationalization, the study successfully proves the impacts of five characteristics of Ordoliberalism, including Politics by rules, Economic Constitution

APA, Harvard, Vancouver, ISO, and other styles

40

Baljer, Nico. "Between rent-seekers and free-marketeers : the economic policy preferences and political influence of German and Swiss pharmaceutical multinationals and banks." Thesis, London School of Economics and Political Science (University of London), 2001. http://etheses.lse.ac.uk/2876/.

Full text

Abstract:

The purpose of this study is to analyse the economic policy preferences and political influence of a sample of German and Swiss pharmaceutical multinationals and banks. Put differently, the goal is to examine whether these MNEs have the will, and the political clout, to promote a liberal economic order or whether they seek to distort, or even suspend, the free formation of prices. In a sense, this study is thus a two-step procedure: first, it will analyse the formation of MNEs' preferences and then, second, it will examine how these preferences translate into political influence and policy out

APA, Harvard, Vancouver, ISO, and other styles

41

Boring, Anne. "L'influence de l'industrie pharmaceutique sur la politique commerciale des Etats-Unis : the influence of the pharmaceutical industry on US trade policy." Paris 9, 2012. https://portail.bu.dauphine.fr/fileviewer/index.php?doc=2012PA090029.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

de, Andrade Marisa. "Pharmaffiliation : a model of intra-elite communication in pharmaceutical regulation." Thesis, University of Stirling, 2011. http://hdl.handle.net/1893/6500.

Full text

Abstract:

In 2005, the House of Commons (HoC) Health Committee produced a report on The Influence of the Pharmaceutical Industry – the first of its kind since 1914. The inquiry concluded that there were ‘over-riding concerns about the volume, extent and intensity of the industry’s influence, not only on clinical medicine and research but also on patients, regulators, the media, civil servants and politicians’, and stressed the need ‘to examine critically the industry’s impact on health to guard against excessive and damaging dependencies’ (HoC 2005, p. 97). It also noted that it is important to comprehe

APA, Harvard, Vancouver, ISO, and other styles

43

Donnelly, Neil James Public Health &amp Community Medicine Faculty of Medicine UNSW. "The use of interrupted time series analysis to evaluate the impact of Pharmaceutical Benefits Scheme policies on drug utilisation in Australia." Awarded by:University of New South Wales. Public Health and Community Medicine, 2005. http://handle.unsw.edu.au/1959.4/22509.

Full text

Abstract:

PROBLEM INVESTIGATED: Methodological issues and policy implications arising from the application of interrupted time series (ITS) analyses to assess the impact of Pharmaceutical Benefit Scheme (PBS) subsidisation policies on drug utilisation in Australia. PROCEDURES FOLLOWED: A critical review of methodological issues relating to the application and analysis of ITS designs was undertaken. This included an examination of drug utilisation data sources in Australia. The PBS policies examined were: (i) the introduction of copayments in 1990; (ii) the introduction of re-supply limits in 1994 and

APA, Harvard, Vancouver, ISO, and other styles

44

Magadzire, Bvudzai Priscilla. "Understanding the dynamics of accessing chronic medicines in the public sector: Implications for policy in South Africa." University of the Western Cape, 2016. http://hdl.handle.net/11394/6298.

Full text

Abstract:

Philosophiae Doctor - PhD (School of Public Health)<br>Access to medicines (ATM), specifically for those medicines that are related to the priority health needs of a population has been cited as a fundamental part of universal health coverage and a key element for service delivery and high-quality care. Therefore, ensuring reliable access to and appropriate use of safe, effective and affordable medicines is one of the core functions of an effective health system. With the rising demand for treatment of chronic diseases (e.g. HIV, diabetes and hypertension), ATM has increasingly received g

APA, Harvard, Vancouver, ISO, and other styles

45

Ludick, Christopher Vernon. "Assessing the micro-economic impact of HIV/AIDS on a South African pharmaceutical manufacturer as well as evaluating their policy on HIV/AIDS." Thesis, Stellenbosch : Stellenbosch University, 2004. http://hdl.handle.net/10019.1/49857.

Full text

Abstract:

Thesis (MBA)--Stellenbosch University, 2004.<br>ENGLISH ABSTRACT: HIV infection has increased sharply in SA over the past decade, from almost zero to a level where between 4-6 million citizens are estimated to be HIV positive (i.e. around Il percent of the total population). Given the considerable lag and link between the HIV and AIDS epidemic, the mortality consequences of this exponential increase in HIV infection over the 1990s are more or less matter-of-fact over the coming decade; even drastic interventions can do little to avoid this reality, albeit possibly impactingfurther beyond

APA, Harvard, Vancouver, ISO, and other styles

46

Henge-Daweti, Vatiswa. "Activities, functions and structure of public sector pharmaceutical and therapeutics committees in the Eastern Cape Province, South Africa." Thesis, Nelson Mandela Metropolitan University, 2017. http://hdl.handle.net/10948/15945.

Full text

Abstract:

The Council of Australian Therapeutic Advisory Groups (CATAG) (2013) define a Pharmaceutical and Therapeutics Committee (PTC) as a ‘multi-disciplinary team committee with a commitment to the overall governance of the medicines management system in health service organizations to ensure the judicious, appropriate, safe, effective and cost-effective use of medicines’. The multi-disciplinary team includes the health care providers, who are actively participating in the health care systems, such as doctors, pharmacists, nurses, administrators, finance officers, quality improvement managers and oth

APA, Harvard, Vancouver, ISO, and other styles

47

Vasiliaková, Beáta. "Lieková politika v ČR." Master's thesis, Vysoká škola ekonomická v Praze, 2007. http://www.nusl.cz/ntk/nusl-15562.

Full text

Abstract:

Thesis is focused on drug system development in Czech Republic during years 2000 to 2008, on study of present circumstances and on key features comparison with its development in selected European countries. Author has described drug system functioning, its participants and relations among them set to Czech Republic. Attention is paid especially to sources of rise in prices of drugs and to growth in consumption, then to safety and awareness of current medication. Factors effecting total expenses on drugs are investigated and participation of total expenses on drugs on total health expenses is

APA, Harvard, Vancouver, ISO, and other styles

48

Brown, Shonda Dellena. "An Information Privacy Examination of the Practices of Pharmaceutical Companies Regarding Use of Information Collected Through Their Websites." NSUWorks, 2015. http://nsuworks.nova.edu/gscis_etd/47.

Full text

Abstract:

Consumers have begun to take a more proactive approach to their healthcare by accessing pharmaceutical companies Websites to obtain health and drug information, support groups, rebates, coupons, as well as free drug trials. In exchange for these benefits, companies require consumers to voluntarily disclose information. However, research has shown that consumers continue to be concerned about how their information is managed, used, and distributed by companies, especially if accessed via the Web. To date, there has been limited empirical research to examine the actual online practices of compan

APA, Harvard, Vancouver, ISO, and other styles

49

Gardner, Le Gars Joanne Claire. "The implications of wicked problems for the legitimacy of European environmental policy development : the case of environmental risks from the pharmaceutical endocrine disrupter, 17α-ethinyl oestradiol, under the European Water Framework Directive". Thesis, University of Exeter, 2018. http://hdl.handle.net/10871/33737.

Full text

Abstract:

The issue of environmental risks from the pharmaceutical endocrine disrupter 17 alpha-ethinyl oestradiol (EE2), which is an active ingredient in the contraceptive pill, confronts government responsibilities for citizens' health with potential environmental risks from its presence in aquatic ecosystems. Further to a risk appraisal process conducted under the Water Framework Directive (WFD) between 2006 and 2012, the European Commission recommended the imposition of an environmental quality standard for EE2. In 2013, this recommendation was rejected by politicians. The outcome was both contested

APA, Harvard, Vancouver, ISO, and other styles

50

Mora, Cole. "A Tough Pill to Swallow: PhRMA and Pharmaceutical Lobbying in the Context of the Affordable Care Act." Scholarship @ Claremont, 2017. http://scholarship.claremont.edu/cmc_theses/1544.

Full text

Abstract:

What is lobbying, properly understood, in the United States, and what strategies and tactics—including and especially those determined by contextual factors, as well as firm characteristics—are commonly employed by corporate lobbies as they operate in our American political environments? Considering this, what are the main strategies and tactics employed by the pharmaceutical lobby, with a particular focus on the Pharmaceutical Manufacturers and Researchers of America, or PhRMA? Finally, what roles did PhRMA play in the development and passage of the Obama administration’s Affordable Care Act,

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!